| Literature DB >> 27261899 |
Ryan A McConnell1, Uma Mahadevan2.
Abstract
For many women with inflammatory bowel disease (IBD), the illness coincides with their childbearing years. IBD increases the risk of pregnancy complications and adverse pregnancy outcomes. The multidisciplinary care team should emphasize the importance of medication adherence to achieve preconception disease control and maintain corticosteroid-free remission throughout pregnancy. Medication adjustments to reduce fetal exposure may be considered on an individualized basis in quiescent disease; however, any benefits of such adjustments remain theoretic and there is risk of worsening disease activity. Mode of delivery is determined by obstetric indications, except for women with active perianal disease who should consider cesarean delivery.Entities:
Keywords: Breast feeding; Crohn disease; Drug-related side effects and adverse reactions; Fertility; Inflammatory bowel disease; Obstetric delivery; Pregnancy; Ulcerative colitis
Mesh:
Substances:
Year: 2016 PMID: 27261899 DOI: 10.1016/j.gtc.2016.02.006
Source DB: PubMed Journal: Gastroenterol Clin North Am ISSN: 0889-8553 Impact factor: 3.806